SS
Sue Siegel
Board Member
San Francisco Bay Area
Overview
Sue Siegel is a highly accomplished Board Director and Trustee with a background as a CEO, C-Suite Executive, and VC. Currently serving on the boards of Align Technology, Illumina, and Nevro, she has an extensive track record in leadership roles within the healthcare, technology, and biotech sectors, with notable achievements including her tenure as Chief Innovation Officer at GE and investments in companies like On-Q-ity and PacBio.
Work Experience
Board Member, Committees: Nom & Gov | Technology (NASDAQ: ALGN)
2017 - Current
Align Technology, Inc. designs, manufactures, and markets the invisalign system for treating malocclusion or the misalignment of teeth.
Raised $136,000,000.00 from ABS Ventures, The Carlyle Group, Oak Hill Capital Partners, QuestMark Partners, Domain Associates and Kleiner Perkins.
Board Member, Committee: Chair, Compensation (2023); Audit (2019-23) (NASDAQ: ILMN)
2019
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Raised $1,278,000,000.00 from Bank of America.
Board Member, Committee: Compensation (NYSE: NVRO)
2020
Chairman, Board of Directors
2020
Board Member
2016 - 2020
Board Member/Trustee, Committee: Investment, Chair
2019
Senior Lecturer @ MIT Sloan
2019
Chief Innovation Officer, GE & CEO, GE Business Innovations
2017 - 2019
CEO, GE Ventures & Licensing
2013 - 2019
CEO, GE Ventures & Healthymagination
2012 - 2017
GE Intelligent Platforms is a global provider of software, hardware, services, and embedded computing platforms.
Board of Directors
2006 - 2013
Board Member; Committee: Compensation
2010 - 2012
Corventis is committed to improving clinical outcomes and lowering healthcare costs by enabling the early detection of cardiovascular
Raised $26,920,006.00.
Chairman, Board of Directors; Compensation; Nominating & Governance
2009 - 2012